HIGHLIGHTS
- who: Magdalena Zaborowska-Szmit and colleagues from the Department of Lung Cancer and Thoracic Tumors, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland have published the paper: Beta Blockers with Statins May Decrease All-Cause Mortality in Patients with Cardiovascular Diseases and Locally Advanced Unresectable Non-Small-Cell Lung Cancer after Chemoradiotherapy, in the Journal: (JOURNAL)
- what: The aim of the study was to check whether the presence of cardiovascular diseases (CVD) and their pharmacotherapy affects the overall survival (OS) in such NSCLC patients undergoing sequential CRT. A decrease in mortality due to . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.